Plasma catecholamines: experience with a single-isotope radioenzymatic assay

Area of Science:

• Clinical Chemistry
• Biochemical Assays
• Endocrinology

Background:

• Plasma catecholamines, including adrenaline and noradrenaline, are crucial biomarkers.
• Accurate measurement is vital for diagnosing neuroendocrine tumors like phaeochromocytoma.
• Existing assays may lack the sensitivity or speed required for routine clinical use.

Purpose of the Study:

• To evaluate a rapid and sensitive single-isotope radioenzymatic assay for plasma catecholamines.
• To assess the utility of plasma catecholamines as tumor markers in phaeochromocytoma management.

Main Methods:

• Implementation of a single-isotope radioenzymatic assay in a clinical chemistry laboratory setting.
• Analysis of plasma samples for adrenaline and noradrenaline concentrations.

Main Results:

• The assay demonstrated good performance characteristics for routine clinical use.
• Elevated plasma adrenaline and noradrenaline levels were observed in patients with phaeochromocytoma.

Conclusions:

• The developed radioenzymatic assay is a valuable tool for plasma catecholamine measurement.
• Plasma catecholamines serve as effective tumor markers in the diagnosis, localization, and monitoring of phaeochromocytoma.
• This assay supports improved patient management for phaeochromocytoma.